Joint Formulary & PAD

Ethinylestradiol with drospirenone - Menstrual disorders and hormone-related gynaecological conditio

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important
Preferred

Preferred brands: Yacella, Dretine.

Combined hormonal contraceptives - used for a variety of disorders including uterine fibroids, menopausal symptoms, endometriosis, dysmenorrhoea, menorrhagia. Off-label use

 

Status 2

Non Formulary
Formulations :
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

Lucette, Ellanite, Yasmin, Eloine - Not recommended for new initiations. Exisitng patients may remain on this brand.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ethinylestradiol with drospirenone
Indication :
Menstrual disorders and hormone-related gynaecological conditions
Group Name :
Keywords :
combined hormonal contraceptives, CHC, uterine fibroids, endometriosis, menorrhagia, heavy menstrual bleeding, dysmenorrhoea, menopausal symptoms, perimenopause symptoms, hot flushes, irregular periods, night sweats
Brand Names Include :
Lucette, Yacella, Dretine, Ellanite, Yasmin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Ethinylestradiol with drospirenone is used to treat.